Your browser doesn't support javascript.
loading
Metronomic combination chemotherapy using everolimus and etoposide for the treatment of non-Hodgkin lymphoma.
Wu, Ke; Sun, Xiao-Qing; Wang, Cai-Qin; Gao, Tian-Xiao; Sun, Peng; Wang, Yu; Jiang, Wen-Qi; Li, Zhi-Ming; Huang, Jia-Jia.
Afiliação
  • Wu K; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Sun XQ; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Wang CQ; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Gao TX; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Sun P; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Wang Y; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Jiang WQ; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Li ZM; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Huang JJ; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Cancer Med ; 8(10): 4688-4698, 2019 08.
Article em En | MEDLINE | ID: mdl-31218841
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica / Etoposídeo / Everolimo / Proteínas Relacionadas à Autofagia Limite: Humans Idioma: En Revista: Cancer Med Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica / Etoposídeo / Everolimo / Proteínas Relacionadas à Autofagia Limite: Humans Idioma: En Revista: Cancer Med Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos